Intercept Pharmaceuticals (ICPT)

P/S ratio on January 10, 2024 (TTM) : 2.50

According to Intercept Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 11.1. At the end of 2023 the company had a P/S ratio of 2.44.

P/S ratio history for Intercept Pharmaceuticals from 2012 to 2023

PS ratio at the end of each year

Year	P/S ratio	Change
2023	2.44	50.09%
2022	1.63	22.76%
2021	1.32	-49.19%
2020	2.61	-83.87%
2019	16.2	-2.94%
2018	16.6	48.64%
2017	11.2	-89.63%
2016	108	-91.75%
2015	> 1000	-31.78%
2014	> 1000	135.06%
2013	816	252.85%
2012	231

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
Eli Lilly LLY	16.5	558.08%	🇺🇸 USA
Bristol-Myers Squibb BMY	2.52	0.62%	🇺🇸 USA
Gilead Sciences GILD	4.04	61.61%	🇺🇸 USA
MediciNova MNOV	104	4,076.18%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for Intercept Pharmaceuticals (ICPT)

P/S ratio on January 10, 2024 (TTM) : 2.50